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Clinical and Imaging Characteristics of Arteriopathy
Subtypes in Children with Arterial Ischemic Stroke:
Results of the VIPS Study
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X G. Zhu, X C. Leiva-Salinas, X Q. Hou, X H.J. Fullerton, and the VIPS Investigators
ABSTRACT
BACKGROUND AND PURPOSE: Childhood arteriopathies are rare but heterogenous, and difﬁcult to diagnose and classify, especially by
nonexperts.We quantiﬁed clinical and imaging characteristics associatedwith childhood arteriopathy subtypes to facilitate their diagnosis
and classiﬁcation in research and clinical settings.
MATERIALS AND METHODS: The Vascular Effects of Infection in Pediatric Stroke (VIPS) study prospectively enrolled 355 children with
arterial ischemic stroke (2010–2014). A central team of experts reviewed all data to diagnose childhood arteriopathy and classify subtypes,
including arterial dissection and focal cerebral arteriopathy–inﬂammatory type, which includes transient cerebral arteriopathy,Moyamoya
disease, and diffuse/multifocal vasculitis. Only children whose stroke etiology could be conclusively diagnosed were included in these
analyses. We constructed logistic regression models to identify characteristics associated with each arteriopathy subtype.
RESULTS: Among 127 children with deﬁnite arteriopathy, the arteriopathy subtype could not be classiﬁed in 18 (14%). Moyamoya disease
(n 34) occurred mostly in children younger than 8 years of age; focal cerebral arteriopathy–inﬂammatory type (n 25), in children 8–15
years of age; and dissection (n 26), at all ages. Vertigo at stroke presentation was common in dissection. Dissection affected the cervical
arteries, while Moyamoya disease involved the supraclinoid internal carotid arteries. A banded appearance of the M1 segment of the
middle cerebral artery was pathognomonic of focal cerebral arteriopathy–inﬂammatory type but was present in25% of patients with focal
cerebral arteriopathy–inﬂammatory type; a small lenticulostriate distribution infarct was amore common predictor of focal cerebral arteriopa-
thy–inﬂammatory type, present in 76%. It remained difﬁcult to distinguish focal cerebral arteriopathy–inﬂammatory type from intracranial
dissection of the anterior circulation. We observed only secondary forms of diffuse/multifocal vasculitis, mostly due to meningitis.
CONCLUSIONS: Childhood arteriopathy subtypes have some typical features that aid diagnosis. Better imagingmethods, including vessel
wall imaging, are needed for improved classiﬁcation of focal cerebral arteriopathy of childhood.
ABBREVIATIONS: FCA  focal cerebral arteriopathy of childhood; FCA-d  focal cerebral arteriopathy–dissection type; FCA-i  focal cerebral arteriopathy–
inﬂammatory type; TCA transient cerebral arteriopathy; VIPS Vascular Effects of Infection in Pediatric Stroke
Approximately 2500 children in the United States have an ar-terial ischemic stroke each year.1 Childhood arteriopathies
are the most common identifiable cause of arterial ischemic
stroke (in a previously healthy child, present in up to 64%).2-6
They represent a strong predictor of recurrent stroke, with rates
exceeding 30% within 12 months for some arteriopathy sub-
types,2,7,8 and published guidelines for the prevention of recurrence
are specific to type (eg, dissection, Moyamoya disease, transient ce-
rebral arteriopathy, and so forth).9 Nonetheless, childhood arte-
riopathies remain difficult to not only diagnose but classify; they are
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rare but heterogeneous, and MRA imaging, frequently substituted
for conventional angiography, is technically limited. Publication
of consensus-based definitions of childhood arteriopathy in 2004
(adapted for the Vascular Effects of Infection in Pediatric Stroke
[VIPS] study in 2009) and the development of the Interbody Fu-
sion Devices in the Treatment of Cervicobrachial Syndrome
(CASCADE)10 system in 2012 (which provided a novel approach
to classifying the “anatomic site of disease” in childhood arterial
ischemic stroke) have largely been addressed to pediatric stroke
specialists.
These tools are less useful for nonexperts, however, who are
frequently responsible for making timely decisions crucial to the
prevention of stroke recurrence. It is this gap that in large part, we
seek to address. In the prospective, international, National Insti-
tutes of Health–funded Vascular Effects of Infection in Pediatric
Stroke study, a 4-person teamof pediatric stroke experts classified
the etiology of 355 cases of pediatric arterial ischemic stroke
(based on rigorous central review of neuroimaging and clinical
data). With this “expert opinion” as the criterion standard, the
goal of the current analysis was to guide the classification of child-
hood arteriopathies by quantifying the prevalence and odds ratios
for clinical and imaging biomarkers that were used in the expert
review to do the following: 1) distinguish arteriopathy from car-
dioembolism, and 2) distinguish among the most common sub-
types of childhood arteriopathy. In other words, we aimed to
identify and quantify biomarkers that could allow trained neuro-
radiologists and neurologists who are nonexperts in childhood
arteriopathies to generate a reasonable differential diagnosis for a
child with stroke.
MATERIALS AND METHODS
Study Design
Ethics committee approvals were obtained at all sites. From 2009
to 2014, the VIPS study enrolled 355 children (29 days to 18 years
of age) with arterial ischemic stroke at 37 international sites, col-
lected detailed clinical data (eg, medical history such as cardiac
disease and sickle cell anemia, recent exposures such as infection,
and head trauma), and performed central review of brain and
cerebrovascular imaging (by M.W., H.J.F., G.A.D., and A.J.B.).
Details of VIPS methods have been published.11 As a part of the
VIPS study, an exhaustive and systematic centralized review of
baseline and follow-up vascular imaging and clinical data was
performed to first arrive at a diagnosis of arteriopathy and then to
classify the arteriopathy subtype.12 For this study, we included all
children with abnormal vascular imaging findings that could be
definitively classified as due to arteriopathy or cardioembolism.
Imaging Review
In our review of brain parenchymal imaging, we recorded infarct
size (using ABC/2),13 laterality, location, acuity, and associated
hemorrhage. Vascular imaging findings were first classified as
normal or abnormal and then were completely described with
respect to type of abnormality (eg, hypoplasia, irregularity, band-
ing, stenosis, occlusion, and so forth), vascular territories and
sides affected, number and type of arterial segments affected, and
degree of collateral flow. Details of the VIPS imaging review have
been published.12
Childhood Arteriopathy Classiﬁcation
Two primary reviewers (M.W., H.J.F.) independently used clini-
cal data and parenchymal and vascular imaging features to deter-
mine a diagnosis of either definite, possible, or no arteriopathy
(“primary diagnosis”).12 Disagreements were resolved through
consensus discussion by the full review team (M.W., H.J.F.,
G.A.D., and A.J.B.). We defined arteriopathy as “the imaging ap-
pearance of an in situ arterial abnormality (stenosis, irregularity,
occlusion, banding, pseudoaneurysm, dissection flap) not attrib-
utable to an exogenous thrombus (eg, cardioembolism) and not
considered a normal developmental variant.”12 The imaging find-
ing of an isolated arterial occlusion could be classified as “no
arteriopathy” (eg, if the clinical history and/or the parenchymal
imaging typified cardioembolism), “possible arteriopathy” (eg, if
the differential diagnosis included both cardioembolism and ar-
terial dissection), or “definite arteriopathy” (eg, if the imagingwas
definitive for Moyamoya disease or dissection). The reviewers
then classified the arteriopathies into subtypes (“secondary diag-
nosis”) using pre-established definitions for childhood arteriopa-
thies10,14: arterial dissection, including unilateral focal cerebral
arteriopathy–dissection type (FCA-d, further defined below);
unilateral focal cerebral arteriopathy–inflammatory type (FCA-i),
which includes transient cerebral arteriopathy (TCA); primary
and secondaryMoyamoya disease (bilateral cerebral arteriopathy
of childhood); genetic or syndromic arteriopathies, such as
PHACES (posterior fossa malformations, hemangiomas, arterial
anomalies, cardiac defects, eye abnormalities, and sternal or su-
praumbilical defects), a cutaneous condition characterized by
multiple congenital abnormalities15,16; primary and secondary
diffuse/multifocal vasculitis; fibromuscular dysplasia17; iatrogen-
ic; and others. The primary reviewers independently classified the
secondary diagnosis; disagreements were resolved through con-
sensus discussion by the full review team. The final conclusion
(the expert opinion regarding the stroke etiology of that case)
constituted the criterion standard diagnosis. The diagnoses in the
children included in this study are shown in Fig 1.
The original definition of focal cerebral arteriopathy of child-
hood (FCA) consisted of “stenosis [of intracranial arteries] on
vascular imaging not otherwise classified as dissection, Moya-
moya disease, sickle cell arteriopathy, postvaricella arteriopathy,
vasculitis, or other specific diagnoses (such as postirradiation ar-
teriopathy)” and included “unifocal or multifocal, unilateral, or
bilateral lesions of the large and/or medium-sized vessels visual-
ized on angiography.”7 Use of this term has evolved in the pedi-
atric stroke literature, and in North American pediatric stroke
centers, it is typically used to describe a specific angiographic ap-
pearance of unilateral stenosis and/or irregularity of the intracra-
nial anterior circulation; it has a differential diagnosis including
TCA, intracranial dissection, unilateral Moyamoya disease, and
the other diagnoses listed above.18 Hence, we implemented an
updated definition of FCA: unifocal and unilateral stenosis/irreg-
ularity of the large intracranial arteries of the anterior circulation
(distal internal carotid artery and/or its proximal branches). FCA-
dissection type (FCA-d) referred to intracranial arterial dissection
of the anterior circulation, typically with trauma.19 FCA-inflam-
mation type (FCA-i) referred to FCA that is presumed inflamma-
tory (ie, thought to represent a focal vasculitis). This could be
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diagnosed, for instance, because of marked enhancement of the
abnormal arterial segment on vessel wall imaging20 or preceding
varicella zoster infection (if considered clinically relevant by the
local pediatric stroke neurologist for a diagnosis of postvaricella
arteriopathy).21,22 FCA-i was also diagnosed when the evolution
of the arteriopathywas typical of TCA: a stereotyped,monophasic
natural history characterized by frequent early progression (from
days to weeks), a plateau with nonprogression by 6 months, and
subsequent improvement in some, with complete resolution in a
minority.14,23 FCA that could not be further classified was con-
sidered “undetermined” arteriopathy subtype (in which case the
reviewers created a differential diagnosis).
Statistical Analysis
The outcome variables for our analyses were the stroke etiology
(primary and secondary diagnoses) as classified by the VIPS team.
In children with abnormal vascular imaging findings, arteriopa-
thy must first be distinguished from cardioembolism (primary
diagnosis); to this end, we first developed a predictive model for
cardioembolic stroke.We then addressed our primary goal, mod-
eling clinical and imaging biomarkers associated with the most
commonly diagnosed arteriopathy subtypes (secondary diagno-
sis): dissection, FCA-i,Moyamoya disease, and secondary diffuse/
multifocal vasculitis. By design, we evaluated as predictors bio-
markers that were used by the reviewers in the classification
process; though circular, this evaluation allowed the quantifica-
tion of the prevalence of the biomarker and the strength of its
association with a specific subtype.
For our preliminary model (cardioembolic versus arterio-
pathic stroke), we compared 65 children classified as having spon-
taneous cardioembolism (excluding strokes attributed to cardiac
surgery)with 109with definite arteriopathy (excluding thosewith
possible arteriopathy, but including those whose definite arteri-
opathy could not be further classified; Fig 1). We first used uni-
variate logistic regression models to identify clinical and/or pa-
renchymal and/or vascular imaging characteristics associated
either positively or negatively with these 2 broad categories. We
FIG 1. Classiﬁcation of stroke subtype among 355 childrenwith arterial ischemic stroke enrolled in the VIPS study. The cases used for the current
study are highlighted in gray.
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then constructed a multivariable model by entering all predictors
significant at the .10 level in univariate analysis. Backward-selec-
tion logistic regression analysiswas used to estimate adjusted odds
ratios, with a significance level of .05 specified for removal of a
variable from the model.
We followed a similar process to create models predictive of
each individual arteriopathy subtype. Univariate logistic regres-
sion models were first used to identify characteristics associated
with each subtype individually. For these models, we compared
each subtype with the group of all other subtypes combined (ex-
cluding the 18 subjects with definite arteriopathy that could not
be further classified). In addition to calculating odds ratios and
95% confidence intervals for each potential predictor, we deter-
mined the frequency with which the predictor was observed
within the subtype.We then constructedmultivariablemodels for
each subtype as described for the preliminary model above. All
models were assessed with postestimation techniques, and C-sta-
tistics were compared among potentialmodels. Adjustmentswere
made when necessary to improve the model fit before a final
model was determined. All analyses were performedwith STATA,
Version 14 (StataCorp, College Station, Texas).
RESULTS
All 355 patients with VIPS had initial brain vascular imaging—
MRA (91%), CTA (24%), and/or conventional angiography
(14%); 53% had cervical vascular imaging; and 3.9% had vessel
wall imaging. Overall, 41% had at least 1 follow-up brain vascular
imaging study; the last follow-up was a median of 277 days (in-
terquartile range, 172–408 days) poststroke. Figure 1 demon-
strates the results of the stroke subtype classification. Character-
istics that distinguish cardioembolism from arteriopathic stroke
(with a P value  .10 on univariate analysis) are shown in On-
line Table 1. Characteristics associated with arteriopathy subtype
(with a P value  .10 on univariate analysis) are shown On-line
Tables 2–4. All the variables tested are shown in On-line Tables
5–11. Independent predictors are summarized in the Table and
shown in detail in On-line Table 11.
Cardioembolic versus Arteriopathic Stroke
In multivariable analysis, characteristics determined to best dis-
tinguish cardioembolic from arteriopathic stroke were the pres-
ence of congenital heart disease and involvement of multiple vas-
cular territories (both positively associated with cardioembolic
stroke); the presence of vascular stenosis or irregularity spoke
against the possibility of cardioembolic stroke (Table andOn-line
Table 11). All cases of cardioembolic stroke had underlying con-
genital or acquired cardiac disease (On-line Tables 1 and 5). Hav-
ing multiple or bilateral arterial segments affected unexpectedly
decreased the odds of cardioembolismbecause these featureswere
seen more frequently in arteriopathy. On vascular imaging, the
most common abnormality in cardioembolic stroke was arterial
occlusion, present in almost half; however, arterial occlusion was
a nonspecific finding observed commonly in the arteriopathy
group (61.5% of patients with arteriopathy). Arterial irregulari-
ties and stenosis reduced the odds of cardioembolism, though
each was observed in about 10% of patients with cardioembolic
strokes.
Summary results of independent predictors of arteriopathy subtypes
Arteriopathy Subtype Cardioembolic Dissection FCA-i Moyamoya
Secondary
Vasculitis
Other
Deﬁnite
Demographic characteristics
Black race vs other 
Clinical characteristics
Congenital or acquired heart disease 
Down syndrome 
Meningitis 
Sepsis/bacteremia 
Head trauma 
Presentation
Dysarthria 
Nausea/vomiting 
Vertigo 
Decreased level of consciousness  
Infarct characteristics: location
Lenticulostriate artery territory 
Infarct characteristics: volume
Infarct volume (smaller) 
Vascular imaging abnormal ﬁndings
Occlusion 
Stenosis 
Irregularity 
Banding 
1 vascular territory  
1 arterial segment 
Affected artery
Proximal MCA (M1) 
Distal ICA (supraclinoid)  
Cervical artery 
Note:—Positive association: indicates odds ratio 20;, OR 5–15;, 1 OR 5; P .05 in all. Negative association:, OR 1 and P .05.
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Characteristics of Childhood Arteriopathy Subtypes
Our final multivariable model to distinguish arterial dissection
(intracranial, which includes FCA dissection, or extracranial)
from other arteriopathy subtypes included a history of head
trauma and involvement of the cervical arteries (Table and On-
line Table 11). Arterial dissection was associated with a history
of head trauma in 39% of cases (On-line Tables 2 and 6). Dis-
sections were equally distributed between the anterior and
posterior circulation. Dissections tended to present as unilat-
eral occlusions.
Characteristics associatedwith FCA-i inmultivariable analysis
included presentation with dysarthria, smaller infarcts in the len-
ticulostriate territory, infarct volume of 25 cm3, arterial band-
ing, and isolated involvement of the M1 segment of the middle
cerebral artery (Table and On-line Table 11). FCA-i tended to
occur more often in children between 8 and 15 years of age (On-
line Tables 3 and 7). The banding pattern (Fig 2), while pathogno-
monic, was uncommon (24% of patients with FCA-i).
Forty-one children met the criteria for FCA: 7 with FCA-d, 25
with FCA-i, and 9 who could not be further classified. Our anal-
ysis of characteristics that distinguish FCA-i from FCA-d (On-
line Tables 8 and 9) was limited by small sample sizes and the
availability of vessel wall imaging in only 8 of the 25 children with
FCA-i. The expert review team used a history of head trauma to
make a diagnosis of FCA-d; it was present in 5 of the 7 patients
with FCA-d (and in none of those with FCA-i). Infarct volumes
were larger for FCA-d (median, 88 cm3; interquartile range,
3.3–20 cm3) than for FCA-i (median, 14 cm3; interquartile range,
8.6–99 cm3; P .05). Arterial occlusion was seen in 86% of sub-
jects with FCA-d versus 40%of those with FCA-i (P .06). Band-
ing was seen in 24% of subjects with FCA-i but in none with
FCA-d (P  .28). In contrast, all 7 patients with FCA-d had in-
volvement of both the supraclinoid ICA and M1. A coincident
cervical artery abnormality was more suggestive of FCA-d (4/7
with FCA-d versus 1/25 with FCA-i, P .007).
Our multivariable model for a Moyamoya disease diagnosis
included both primary and secondary forms (Table and On-line
Table 11). Of 34 children with Moyamoya disease, 17 were diag-
nosed with primary (idiopathic) Moyamoya disease, and 17, with
secondaryMoyamoya disease syndrome, most commonly caused
by sickle cell anemia (n  9) or Down syndrome (n  6). An
association between black race andMoyamoya disease was almost
entirely explained by sickle cell anemia; Asian race did not affect
the risk ofMoyamoya disease in our cohort (On-line Tables 4 and
10). Imaging characteristics included bilateral distal ICA occlu-
sion or stenosis and infarcts involving multiple vascular territo-
ries. Involvement of the posterior circulation was present in 21%.
Although Moyamoya disease is an intracranial arteriopathy, ab-
normalities of the cervical arteries were noted in 6 patients (18%)
with this condition, likely representing the MRA finding of small
cervical internal carotid arteries due to reduced intracranial flow.
Patients with Moyamoya disease typically did not present with a
decreased level of consciousness, differentiating them from chil-
dren with secondary vasculitis who had similar distal ICA
involvement.
There were no cases of primary diffuse/multifocal vasculitis in
VIPS, but there were 15 cases of secondary diffuse/multifocal vas-
culitis due to meningitis (n  11), other infection (cavernous
sinus thrombophlebitis, n 1; mycotic aneurysm, n 1), auto-
immune disease (n  1), or other (n  1). Hence, clinical char-
acteristics associated with this diagnosis included meningitis and
bacteremia/sepsis and presentation with a decreased level of con-
sciousness (Table and On-line Table 11). Complete occlusion of
the affected artery reduced the odds of diffuse/multifocal vasculi-
tis. Diffuse/multifocal vasculitis was seen more frequently in
Asian patients: There were 6 cases of stroke due to tubercular
meningitis enrolled in the Philippines.
Among 7 children with Down syndrome in our cohort, 6 had
Moyamoya disease and 1 had a cardioembolic stroke.
DISCUSSION
The diagnosis of childhood arteriopathy is complex, and pediatric
stroke experts have developed their diagnostic acumen across the
years through the cumulative exposure to many cases. However,
because these diseases are rare, pediatric patients with childhood
arteriopathy are often seen by health care professionals who have
not developed this expertise. The VIPS study presented a unique
opportunity to help nonexperts in not only accurately diagnosing
pediatric patients with childhood arteriopathy but also distin-
guishing among specific types based on objectively defined clini-
cal and imaging parameters. The VIPS study previously demon-
strated that arteriopathies can be more accurately classified when
clinical data are used than when imaging findings are used alone,
andwhen follow-up vascular imaging is performed.11 The current
analysis adds to our prior publication by defining the prevalence
and predictive value of the individual characteristics that a pediatric
stroke expert uses to diagnose childhood arteriopathy. In addi-
tion, it allows identification of patterns (ie, combinations of char-
acteristics that distinguish certain arteriopathies) and assessment
of the relative importance of each of these characteristics. This
analysis assumes the availability of complete and accurate clinical
and imaging data at the time of the arteriopathy classification; in
real clinical situations, arteriopathy classification should be revis-
ited as new data become available with time.
As a first step in the approach to vascular imaging abnormal-
FIG 2. Banding pattern observed in 24% of patients with FCA-i.
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ities in a child with arterial ischemic stroke, radiologists and cli-
nicians should consider whether the abnormality represents in-
herent arterial disease (ie, arteriopathy) versus thrombus from a
proximal source (cardioembolism or artery-to-artery embolism).
Underlying cardiac disease strongly favors cardioembolism; how-
ever, 4 children with congenital heart disease had an arteriopathic
stroke (1 with a dissection, 3 with Moyamoya disease), indicating
that arteriopathic stroke should be considered even in patients
with cardiac disease.
Arterial stenosis or irregularity reduces the odds of cardioem-
bolism but can be seen with a recanalizing thrombus. Complete
arterial occlusion appeared to reduce the odds of cardioembolism
in ourmodel but only because it is a common feature of arteriopa-
thies like Moyamoya disease and dissection; it was still the most
common vascular imaging finding in cardioembolism. Distin-
guishing arteriopathy from thrombus remains challenging; our
expert team could not make the distinction in 34 cases (desig-
nated possible arteriopathy, Fig 1), highlighting the need for an
echocardiogram as part of the work-up of pediatric patients sus-
pected of having childhood arteriopathy.
The most common childhood arteriopathies in our cohort of
children presenting with acute arterial ischemic stroke were
Moyamoya disease, arterial dissection (intracranial and extracra-
nial), and FCA-i. This distribution would likely be different in a
cohort including all children with cerebral or cervical arteriopa-
thy; primary small-vessel CNS vasculitis, for example, typically
presents with only headache or cognitive decline and no focal
signs or symptoms. Although atherosclerosis may begin in child-
hood, it was not seen as a cause of stroke in VIPS, consistent with
findings in prior reports.3,24
Age was the one demographic characteristic that helped dis-
tinguish among arteriopathy subtypes. FCA-i tended to affect
older school-aged children, while Moyamoya disease affected
younger children; dissection had no age predilection. Sex and race
did not correlate with arteriopathy subtype (after accounting for
sickle cell disease). Although primary Moyamoya disease occurs
more commonly in Korean and Japanese populations,25 we had
no enrolling sites in those countries and saw a broad distribution
of ethnicities among our subjects with Moyamoya disease.
A diagnosis of dissection is suggested by the involvement of
cervical arteries. On the basis of current definitions, FCA-i does
not include arteriopathies affecting the posterior circulation.
Moyamoya disease predominantly affects the anterior circulation;
posterior circulation involvement, when present, is rarely symp-
tomatic. Hence, dissection is high on the differential in a previ-
ously healthy child presenting with a posterior circulation arterial
ischemic stroke. In addition, FCA-i, Moyamoya disease, and sec-
ondary vasculitis are intracranial arteriopathies; involvement of
the cervical arteries is strongly suggestive of dissection.
Distinguishing the etiologies of FCA—focal stenosis or irreg-
ularity of the distal ICA or proximal MCA—remains a challenge
even to pediatric stroke experts. The differential diagnosis in-
cludes FCA-i, FCA-d (intracranial dissection of the anterior cir-
culation), and early, unilateral Moyamoya disease. All typically
present with hemiparesis, but headache at the stroke ictus is com-
mon in FCA-i and FCA-d, but not inMoyamoya disease. Banding
was considered a pathognomonic feature for FCA-i but was pres-
ent in less than one-quarter of cases (being more conspicuous on
conventional angiograms compared with CTAs and MRAs);
hence, it was useful when present but not a sensitive feature of
FCA-i. Infarct location in the lenticulostriate territory and smaller
infarct size correlated with FCA-i and were more prevalent bio-
markers. However, FCA-i and FCA-d are, in general, difficult to
distinguish from each other as shown in postmortem cases.26
An infarct in the superficial middle cerebral artery territories
(ie, cerebral convexities) was more suggestive of Moyamoya dis-
ease. Chronic deep borderzone infarcts, also common in Moya-
moya disease, do not result in focal deficits; because this is a co-
hort of children with acute arterial ischemic stroke, such infarcts
were not included in this analysis. A history of head trauma
and/or coincident cervical artery abnormalities suggests dissec-
tion. Improved neuroimaging techniques, including vessel wall
imaging,27 are needed to distinguish forms of FCA with greater
certainty, though vessel wall imaging may not be 100% specific
and there may be some overlap, with FCA-d showing minimal
enhancement on vessel wall imaging and FCA-i typically present-
ing with marked enhancement on vessel wall imaging. The dis-
tinction between FCA-d and FCA-i is particularly important be-
cause their management strategies differ. FCA-i and FCA-d are
currently treated with antiplatelet therapy. In addition, life-long
restriction of activities (eg, no contact sports) is often recom-
mended after an arterial dissection,28 and clinical trials of corti-
costeroids for the treatment of FCA-i are under development.
In this article, the definition of FCA-i was restricted to focal
disease of the distal ICA and its proximal branches, including but
not limited to TCA.14,23 However, we anticipate that increased
use of vessel wall imaging,27 allowing the delineation of enhancing
arterial segments, will necessitate a broader definition of FCA. For
example, we observed cases of focal stenosis of the petrous carotid
or posterior circulation arteries that we diagnosed as having a
definite arteriopathy that could not be further classified. If such
cases had vessel wall imaging demonstrating enhancement of the
affected vessel, it may be reasonable to expand the definition of
FCA-i to include these cases. In addition, we identified 1 case of
FCA-i that demonstrated arteriopathy progression after 6
months, contrary to the traditional definition of TCA; this high-
lights the fact that while FCA-i includes TCA, not all cases FCA-i
are TCA.
The main limitation of our study is that there is no
true criterion standard for thediagnosis of childhoodarteriopathies.
Our expert review team was uncertain about the classification in
52 cases: 34 with possible arteriopathy and 18 with a definite ar-
teriopathy that could not be further classified (Fig 1). Even among
the arteriopathies that the review team classified with high cer-
tainty, there was likely somemisclassification that cannot bemea-
sured. Because all imagingwas performed on a clinical basis, there
was variability in both the type and timing of imaging performed.
As noted in our prior study, follow-up vascular imaging was help-
ful for classification, yet it was available in only a minority of
patients.14 The circularity of some analyses—biomarkers used to
classify a subtype and then evaluated as predictors of that sub-
type—must be emphasized; head trauma, for example, was an
anticipated predictor of arterial dissection because it was used in
the classification process. In such cases, the value of the analysis is
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in the prevalence of the predictor, such as noting that a minority
of dissection cases had trauma, so an absence of trauma does not
rule out this diagnosis.
Last, analyses of arteriopathy subtypes were underpowered (as
reflected by large confidence intervals of coefficients in the mul-
tivariable models), so they should be interpreted with caution.
However, advantages of our study include a prospectively col-
lected cohort, a large sample size relative to most pediatric stroke
studies, and rigorous classification methods based on indepen-
dent, central expert reviews and adjudication. Our study allows
the quantification of the prevalence of the predictors, the strength
of their correlations with specific diagnoses, and patterns of mul-
tiple predictors. These results should provide a guide for clinicians
and neuroradiologists to generate a reasonable differential for an
arteriopathic stroke in a child and to prioritize diagnoses on that
list. The application of these findingswill depend, however, on the
accurate characterization of the imaging biomarkers by the inter-
preting neuroradiologist.
CONCLUSIONS
The different types of childhood arteriopathies are associatedwith
typical clinical and parenchymal and vascular imaging features
that can help narrow the differential diagnosis in pediatric patients
with stroke with vascular anomalies (Table).
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